↓ Skip to main content

A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer

Overview of attention for article published in Breast Cancer Research, December 2019
Altmetric Badge

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
63 Mendeley